alexa Abstract | Antiatherogenic effect of Mezzetia parviflora BECC. extract in high cholesterol fed rats

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access


The investigation of anti-atherosclerotic activity of M. parviflora and the mechanisms responsible for the extract’s effects (antihypolipidemic, anti-lipidperoxidation, and monocyte chemoattractant protein-1 (MCP-1) inhibition activities) has been performed. In this study, atherogenesis was induced by feeding rats with a hypercholesterolemic diet (200 mg/Kg day-1) for 3 months. The cholesterol intake was administered along with simvastatin 3.6 mg/Kg or M. parvifloraextract at doses of 100, 300 and500 mg/Kg.Atheroma observation was performed by immunohistochemistry staining method with anti-macrophage antibody (MAC387). Animal plasma biochemical (total cholesterol, trigliserida, HDL, LDL, malondialdehyde, and MCP-1) profiles were measured. M. parvifloraextract dose dependently decreased the total-cholesterol, triglyceride, and LDL-cholesterol levels; and increased HDL-cholesterol in atherogenic-diet rats. Furthermore, M. parvifloraextract lowered the lipidperoxidation (malondilaldehyde, MDA) and MCP-1 production in dose dependent manner. Immunohistochemistry staining with anti-macrophage antibody(MAC387) showed that atherogenic-diet rats treated with M. parvifloraextract at a dose of 500 mg/Kg was not colored positively, the same as that in normal and simvastatin treated groups. These results suggest that M. parviflora-standardized extract may have anti-atherosclerosis effect throughantihiperlipidemia and antilipid-peroxidation activities.

To read the full article Peer-reviewed Article PDF image

Author(s): Mufidah Murdifin Elly Wahyudin Gatot S Lawrence Marianti A Manggau GeminiAlam Ermina Pakki Yulia Y Djabir Aryadi Arsyad and Muh Akbar Bahar


Mezzetia parviflora Becc., Antiatherosclerosis, Antioxidant, Anticholesterol, MCP-1, Antiatherogenic

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version